Seqens
Écully
About Seqens
Seqens is a integrated in pharmaceutical synthesis and specialty ingredients, delivering unrivalled market responsiveness and tailor-made solutions to our customers.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1,001 – 5,000
- Estimated revenue: $1M – $10M
- Funding stage: M&A
- Last round: Private Equity (Jun 2016)
- Website: seqens.comen
Industries & Categories
Biotechnology, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/seqens-185233 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.